Characterizing Antibody-Drug Conjugates Through Innovative Analytical Solutions
From Imaging to Insight: Cell Cycle Mapping in Tumors with Advanced Multiplexing & Spatial Profiling
Bridging the Gap: Advancing Human-Relevant Models for Real-World Impact
Innovative Technologies To Accelerate Identification Of High-Quality Clones Webinar
Innovative AI Software Solutions Driving Biomarker Research Efficiency
A Multiplexed RF-QTOF MS & Genedata Platform for Covalent Ligand Discovery
Chemical Liability Screening for Biotherapeutic Proteins – Using a Proteomic Approach and High-Throughput Data Analysis to Identify Antibody Chemical Liabilities in Early-Stage Discovery
Accelerating Cancer Research: Microplate Reader-Based Viability Analysis for Rapid Drug Candidate Identification in Patient-Derived Organoids
See how the CellXpress.ai Automated Cell Culture System transforms cardiovascular research
Establishing a Sustainable Platform for CRISPR-Based Genome Editing Therapies: An Academic-Industry Partnership Model for Addressing Inborn Errors of Immunity
Rapid and Robust Analytical Solutions for Identifying Clones in Cell Line Development Processes leveraging the ValitaTiter and Valita Aggregation Pure Assay
Advancing Discovery by Enabling the Use of 3D Organoids
Guiding Decisions throughout Drug Development
Learn how AstraZeneca Automates Image Analysis with Deep Learning
Exploring the Tumor Immune Landscape using Multiplexed Imaging and AI-Powered Spatial Analysis
Automation Solutions for Plasmid Construction and Screening
Chromatographic Determination of mRNA Critical Quality Attributes
A Comprehensive Analysis of mRNA-LNPs by capillary electrophoresis
Sequence to Vial
IDT Portfolio and Crispr Overview
